Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saizen for Severe Fibromyalgia with Growth Axis Dysfunction
NCT00933686Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- Dec 2007
- Primary completion
- Jul 2010
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in fibromyalgia (FM), sponsored by Merck KGaA. Started Dec 2007; status: completed.
02
Drugs
somatropin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00933686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00933686.